T

Pharmacokinetics and pharmacodynamics of azithromycin in severe malaria bacterial co-infection in African children

A Phase I/II trial to assess safety and immunogenicity of intradermal (ID) DNA priming, intramuscular (IM) MVA and IM rgp140/GLA-AF boosting in healthy volunteers in Tanzania and to develop further HIV vaccine trial capacity building in Tanzania.

HIV vaccine trial capacity building in Tanzania and Mozambique by continued exploration of optimal DNA priming and MVA boosting strategies

Transfusion Alternatives Pre-operatively in Sickle-cell disease (TAPS) randomised controlled trial

Tuberculosis Child Multidrug-resistant Preventive Therapy Trial

A prospective study of surveillance in stage 1 non-seminomatous testicular tumours

Adjuvant bleomycin, etoposide and cisplatin (BEP) in the treatment of "high risk" stage I non-seminomatous germ cell tumours

A randomised trial of two vs five CT scans in the surveillance of patients with stage I non-seminomatous germ cell tumours of the testis

Randomised trial of carboplatin- vs cisplatin based chemotherapy for good prognosis metastatic non-seminomatous germ cell tumours

A prospective study of risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer

A randomised trial of single agent carboplatin vs etoposide and cisplatin for advanced metastatic seminoma

A randomised trial of BEP (bleomycin, etoposide, cisplatin) vs BOP/VIP-B (bleomycin, vincristine, cisplatin, etoposide, ifosfamide cisplatin, bleomycin) and of the same regimens with or without G-CSF in poor prognosis metastatic germ cell tumours

Prognostic factors for patients with advanced seminoma treated with platinum based chemotherapy

Prognostic factors in patients progressing after platinum-based chemotherapy for metastatic non-seminomatous germ cell tumours

Post chemotherapy residual masses in germ cell tumour patients

Adjuvant bleomycin, vincristine and cisplatin for high-risk stage I non-seminomatous germ cell tumours

A randomised trial of 3 cycles of BEP versus 3 cycles of BEP plus 1 cycle of EP and the 3-day versus the 5-day schedule in good prognosis metastatic germ cell cancer

A randomised trial of BEP vs Taxol-BEP in histologically proven metastatic germ cell cancer with intermediate prognosis

A randomised phase II trial of intensive induction chemotherapy (CBOP/B15EP) and standard BEP chemotherapy in poor prognosis male germ cell tumours

Does giving patients hospitalised with COVID-19 a synthetically made antibody that blocks the virus make them get better more quickly?

The first therapeutic intervention in malignant pleural effusion trial

The second therapeutic intervention in malignant effusion trial

A randomised controlled trial to evaluate whether use of intrapleural urokinase aids the drainage of multi-septated malignant pleural effusion compared to placebo

A Randomised Controlled Trial Of Prophylactic Vs No-Prophylactic Platelet transfusions in Patients with Haematological malignancies

Microbicides Development Programme Top-Up study

Transfusion and Treatment of severe Anaemia in African Children: a randomised controlled Trial

A study to collect blood and tissue samples from consenting patients who have been diagnosed with kidney cancer

Trial of imaging and schedule in seminoma testis

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive Tuberculosis